Related references
Note: Only part of the references are listed.Obesity as a risk factor for COVID-19: an overview
Ricardo Wesley Alberca et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2021)
COVID-19 vaccines: The status and perspectives in delivery points of view
Jee Young Chung et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reports
A. J. Scheen et al.
DIABETES & METABOLISM (2020)
Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication
Yuchen Chen et al.
DIABETES CARE (2020)
Exposure to dipeptidyl-peptidase-4 inhibitors andCOVID-19 among people with type 2 diabetes: A case-control study
Gian Paolo Fadini et al.
DIABETES OBESITY & METABOLISM (2020)
Letter to the editor in response to the article COVID-19 and diabetes: Can DPP4 inhibition play a role?
Visnja Kokic Males
DIABETES RESEARCH AND CLINICAL PRACTICE (2020)
Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
Bertrand Cariou et al.
DIABETOLOGIA (2020)
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Xiaobo Yang et al.
Lancet Respiratory Medicine (2020)
Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France
Francois Montastruc et al.
THERAPIE (2020)
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Lei Fang et al.
LANCET RESPIRATORY MEDICINE (2020)
Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
Sebastiano Bruno Solerte et al.
ACTA DIABETOLOGICA (2020)
Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors
Urszula Radzikowska et al.
ALLERGY (2020)
Characterization of the Inflammatory Response to Severe COVID-19 Illness
Oliver J. McElvaney et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Coronavirus Disease 2019-COVID-19
Kuldeep Dhama et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
Dennis McGonagle et al.
AUTOIMMUNITY REVIEWS (2020)
The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike
Yu Li et al.
ISCIENCE (2020)
The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19
Qing Ye et al.
JOURNAL OF INFECTION (2020)
Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study
Sebastiano Bruno Solerte et al.
DIABETES CARE (2020)
Impact of Comorbidities and Glycemia at Admission and Dipeptidyl Peptidase 4 Inhibitors in Patients With Type 2 Diabetes With COVID-19: A Case Series From an Academic Hospital in Lombardy, Italy
Marco Mirani et al.
DIABETES CARE (2020)
Structural and functional modelling of SARS-CoV-2 entry in animal models
Greg N. Brooke et al.
SCIENTIFIC REPORTS (2020)
Investigation of CD26, a potential SARS-CoV-2 receptor, as a biomarker of age and pathology
Animesh Alexander Raha et al.
BIOSCIENCE REPORTS (2020)
The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea
Mi Kyung Kim et al.
DIABETES & METABOLISM JOURNAL (2020)
Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26
Naveen Vankadari et al.
EMERGING MICROBES & INFECTIONS (2020)
Therapeutic Effects of Endogenous Incretin Hormones and Exogenous Incretin-Based Medications in Sepsis
Faraaz Ali Shah et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Leptin Function and Regulation
Yiying Zhang et al.
COMPREHENSIVE PHYSIOLOGY (2018)
Anti-inflammatory effects on ischemia/reperfusion-injured lung transplants by the cluster of differentiation 26/dipeptidylpeptidase 4 (CD26/DPP4) inhibitor vildagliptin
Jae-Hwi Jang et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2017)
Polyarthropathy in type 2 diabetes patients treated with DPP4 inhibitors
Tatsuhiko Saito et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2013)
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
V. Stalin Raj et al.
NATURE (2013)
STRING: a database of predicted functional associations between proteins
C von Mering et al.
NUCLEIC ACIDS RESEARCH (2003)
Share Paper
